Table 5.

Factors related to the occurrence of at least one side effects.

	Crude OR (IC 95%)	p-value	Adjusted OR (IC 95%)	p-value
Leuprolide treatment	0.80 (0.37–1.71)	0.558	1.79 (0.74–4.36)	0.199
Days treatment	1.00 (1.00–1.00)	0.069	1.00 (1.00–1.00)	0.113
Weight (kg)	1.01 (0.95–1.08)	0.772
Height (cm)	0.97 (0.92–1.02)	0.223
Chronological age	0.84 (0.51–1.51)	0.517
Initial bone age	0.67 (0.46–0.98)	0.038	0.67 (0.46–0.98)	0.038
Hormones
FSH (mUI/ml)	1.06 (0.87–1.29)	0.566
LH (mUI/ml)	0.83 (0.60–1.14)	0.246
FSH peak (mUI/ml)	0.99 (0.92–1.07)	0.881
LH peak (mUI/ml)	0.99 (0.97–1.01)	0.387
E2 (pg/ml)	1.01 (0.99–1.03)	0.462
SMC (ng/ml)	1.00 (0.99–1.00)	0.306
Longitudinal diameter (mm)	0.98 (0.93–1.03)	0.376
Uterine body/cervix (mm)	1.38 (0.67–2.81)	0.383
Endometrial (mm)	1.58 (0.70–3.53)	0.268
Ovarian volume (cc)	1.12 (0.93–1.37)	0.238